Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis. Amor S, van der Star BJ, Bosca I, Raffel J, Gnanapavan S, Watchorn J, Kuhle J, Giovannoni G, Baker D, Malaspina A, et al. Mult Scler. 2014 Feb 10. PMID: 24515731. Abstract CommentRecommendBookmarkWatch